BioNTech Weighs Making Covid Shots in Africa to Expand Reach
- Africa far behind wealthy nations in pace of vaccinations
- CEO Sahin says giving up patent rights isn’t the solution
This article is for subscribers only.
BioNTech SE is discussing the possibility of Covid-19 vaccine production sites in Africa to expand the company’s supply network in regions around the world, Chief Executive Officer Ugur Sahin said.
“I can imagine a production network in South America and for Africa,” Sahin said at a briefing with members of Germany’s foreign press association. “We are also talking about African production sites.”